SNCA and synucleinopathy: Another study showed that active immunization using α-synuclein peptides reduced the accumulation of α-synuclein oligomers (but not monomers) and ameliorated the behavioral and neurodegenerative pathology in two different transgenic models of synucleinopathies [20, 21].